PD-151194

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NamePD-151194

Drug Alias NamePD-151194

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics

Mechanisms of ActionCell wall inhibitorsDNA topoisomerase inhibitors

TargetsDNA topoisomerase

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A